Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websitecontrafect.com
CategoryBioTech
Phone(212) 359-9553
Employees
Founded2008

Offices

New York, USA
469 7th Avenue
3rd Floor
New York, NY, 10018
USA

People

Chairmain, CEO
EVP, CFO
Chief Scientific Officer

Funding

TOTAL $16.8M
FUNDING TOTAL $16.8M
Partial Close, 8/2010
Equity Source Partners
$4.33M
Partial Close, 9/2011
Maxim Group
$12.5M
DEBT TOTAL $12M
Debt, 9/2013
$12M

Tags

ContraFect

ContraFect is a biotechnology company pioneering the use of monoclonal antibodies to treat life-threatening infectious diseases.

Recent Milestones

Videos

Screenshots

Sources

  1. SEC (sec.gov) [edit]
  2. SEC (sec.gov) [edit]
  3. SEC (sec.gov) [edit]
  4. Chinese Group Makes Strategic Investment in Yonkers Biotechnology Company (biospace.com) [edit]
Edit This Page
Last Edited 3/3/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy